APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ceritinib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ceritinib Market Analysis and Forecast 2026-2032

23 December 2025196 pages

Choose your research edition.

Industry ResearchCeritinib Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Ceritinib Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Ceritinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ceritinib Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ceritinib Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Ceritinib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ceritinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ceritinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ceritinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ceritinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ceritinib include Lucius Pharmaceuticals, Natco and Novartis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ceritinib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ceritinib, also provides the sales of main regions and countries. Of the upcoming market potential for Ceritinib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ceritinib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ceritinib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ceritinib sales, projected growth trends, production technology, application and end-user industry.

Ceritinib Segment by Company

Lucius Pharmaceuticals

Natco

Novartis

Ceritinib Segment by Type

90 Capsules/Box

50 Capsules/Box

150 Capsules/Box

Ceritinib Segment by Application

Clinic

Hospital

Pharmacy

Others

Ceritinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceritinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ceritinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceritinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ceritinib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ceritinib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ceritinib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ceritinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 90 Capsules/Box Major Manufacturers Table 3. 50 Capsules/Box Major Manufacturers Table 4. 150 Capsules/Box Major Manufacturers Table 5. Global Ceritinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Clinic Major Manufacturers Table 7. Hospital Major Manufacturers Table 8. Pharmacy Major Manufacturers Table 9. Others Major Manufacturers Table 10. Ceritinib Industry Trends Table 11. Ceritinib Industry Drivers Table 12. Ceritinib Industry Opportunities and Challenges Table 13. Ceritinib Industry Restraints Table 14. Global Ceritinib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Ceritinib Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Ceritinib Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Ceritinib Revenue Market Share by Region (2021-2026) Table 18. Global Ceritinib Revenue Market Share by Region (2027-2032) Table 19. Global Ceritinib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k pcs) Table 20. Global Ceritinib Sales by Region (2021-2026) & (k pcs) Table 21. Global Ceritinib Sales by Region (2027-2032) & (k pcs) Table 22. Global Ceritinib Sales Market Share by Region (2021-2026) Table 23. Global Ceritinib Sales Market Share by Region (2027-2032) Table 24. Global Ceritinib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Ceritinib Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Ceritinib Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Ceritinib Sales Market Share by Manufacturers (2021-2026) Table 28. Global Ceritinib Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 29. Global Ceritinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Ceritinib Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Ceritinib Manufacturers, Product Type & Application Table 32. Global Ceritinib Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Ceritinib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Ceritinib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Ceritinib Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Ceritinib Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Ceritinib Revenue Market Share by Type (2021-2026) Table 39. Global Ceritinib Revenue Market Share by Type (2027-2032) Table 40. Global Ceritinib Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 41. Global Ceritinib Sales by Type (2021-2026) & (k pcs) Table 42. Global Ceritinib Sales by Type (2027-2032) & (k pcs) Table 43. Global Ceritinib Sales Market Share by Type (2021-2026) Table 44. Global Ceritinib Sales Market Share by Type (2027-2032) Table 45. Global Ceritinib Price by Type (2021-2026) & (US$/pcs) Table 46. Global Ceritinib Price by Type (2027-2032) & (US$/pcs) Table 47. Global Ceritinib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Ceritinib Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Ceritinib Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Ceritinib Revenue Market Share by Application (2021-2026) Table 51. Global Ceritinib Revenue Market Share by Application (2027-2032) Table 52. Global Ceritinib Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 53. Global Ceritinib Sales by Application (2021-2026) & (k pcs) Table 54. Global Ceritinib Sales by Application (2027-2032) & (k pcs) Table 55. Global Ceritinib Sales Market Share by Application (2021-2026) Table 56. Global Ceritinib Sales Market Share by Application (2027-2032) Table 57. Global Ceritinib Price by Application (2021-2026) & (US$/pcs) Table 58. Global Ceritinib Price by Application (2027-2032) & (US$/pcs) Table 59. Lucius Pharmaceuticals Company Information Table 60. Lucius Pharmaceuticals Business Overview Table 61. Lucius Pharmaceuticals Ceritinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 62. Lucius Pharmaceuticals Ceritinib Product Portfolio Table 63. Lucius Pharmaceuticals Recent Development Table 64. Natco Company Information Table 65. Natco Business Overview Table 66. Natco Ceritinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 67. Natco Ceritinib Product Portfolio Table 68. Natco Recent Development Table 69. Novartis Company Information Table 70. Novartis Business Overview Table 71. Novartis Ceritinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 72. Novartis Ceritinib Product Portfolio Table 73. Novartis Recent Development Table 74. North America Ceritinib Revenue by Type (2021-2026) & (US$ Million) Table 75. North America Ceritinib Revenue by Type (2027-2032) & (US$ Million) Table 76. North America Ceritinib Sales by Type (2021-2026) & (k pcs) Table 77. North America Ceritinib Sales by Type (2027-2032) & (k pcs) Table 78. North America Ceritinib Sales Price by Type (2021-2026) & (US$/pcs) Table 79. North America Ceritinib Sales Price by Type (2027-2032) & (US$/pcs) Table 80. North America Ceritinib Revenue by Application (2021-2026) & (US$ Million) Table 81. North America Ceritinib Revenue by Application (2027-2032) & (US$ Million) Table 82. North America Ceritinib Sales by Application (2021-2026) & (k pcs) Table 83. North America Ceritinib Sales by Application (2027-2032) & (k pcs) Table 84. North America Ceritinib Sales Price by Application (2021-2026) & (US$/pcs) Table 85. North America Ceritinib Sales Price by Application (2027-2032) & (US$/pcs) Table 86. North America Ceritinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Ceritinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 88. North America Ceritinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 89. North America Ceritinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 90. North America Ceritinib Sales by Country (2021-2026) & (k pcs) Table 91. North America Ceritinib Sales by Country (2027-2032) & (k pcs) Table 92. North America Ceritinib Sales Price by Country (2021-2026) & (US$/pcs) Table 93. North America Ceritinib Sales Price by Country (2027-2032) & (US$/pcs) Table 94. United States Ceritinib Revenue (2021-2032) & (US$ Million) Table 95. Canada Ceritinib Revenue (2021-2032) & (US$ Million) Table 96. Mexico Ceritinib Revenue (2021-2032) & (US$ Million) Table 97. Europe Ceritinib Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Ceritinib Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Ceritinib Sales by Type (2021-2026) & (k pcs) Table 100. Europe Ceritinib Sales by Type (2027-2032) & (k pcs) Table 101. Europe Ceritinib Sales Price by Type (2021-2026) & (US$/pcs) Table 102. Europe Ceritinib Sales Price by Type (2027-2032) & (US$/pcs) Table 103. Europe Ceritinib Revenue by Application (2021-2026) & (US$ Million) Table 104. Europe Ceritinib Revenue by Application (2027-2032) & (US$ Million) Table 105. Europe Ceritinib Sales by Application (2021-2026) & (k pcs) Table 106. Europe Ceritinib Sales by Application (2027-2032) & (k pcs) Table 107. Europe Ceritinib Sales Price by Application (2021-2026) & (US$/pcs) Table 108. Europe Ceritinib Sales Price by Application (2027-2032) & (US$/pcs) Table 109. Europe Ceritinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Europe Ceritinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. Europe Ceritinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. Europe Ceritinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 113. Europe Ceritinib Sales by Country (2021-2026) & (k pcs) Table 114. Europe Ceritinib Sales by Country (2027-2032) & (k pcs) Table 115. Europe Ceritinib Sales Price by Country (2021-2026) & (US$/pcs) Table 116. Europe Ceritinib Sales Price by Country (2027-2032) & (US$/pcs) Table 117. Germany Ceritinib Revenue (2021-2032) & (US$ Million) Table 118. France Ceritinib Revenue (2021-2032) & (US$ Million) Table 119. U.K. Ceritinib Revenue (2021-2032) & (US$ Million) Table 120. Italy Ceritinib Revenue (2021-2032) & (US$ Million) Table 121. Russia Ceritinib Revenue (2021-2032) & (US$ Million) Table 122. Spain Ceritinib Revenue (2021-2032) & (US$ Million) Table 123. Netherlands Ceritinib Revenue (2021-2032) & (US$ Million) Table 124. Switzerland Ceritinib Revenue (2021-2032) & (US$ Million) Table 125. Sweden Ceritinib Revenue (2021-2032) & (US$ Million) Table 126. Poland Ceritinib Revenue (2021-2032) & (US$ Million) Table 127. China Ceritinib Revenue by Type (2021-2026) & (US$ Million) Table 128. China Ceritinib Revenue by Type (2027-2032) & (US$ Million) Table 129. China Ceritinib Sales by Type (2021-2026) & (k pcs) Table 130. China Ceritinib Sales by Type (2027-2032) & (k pcs) Table 131. China Ceritinib Sales Price by Type (2021-2026) & (US$/pcs) Table 132. China Ceritinib Sales Price by Type (2027-2032) & (US$/pcs) Table 133. China Ceritinib Revenue by Application (2021-2026) & (US$ Million) Table 134. China Ceritinib Revenue by Application (2027-2032) & (US$ Million) Table 135. China Ceritinib Sales by Application (2021-2026) & (k pcs) Table 136. China Ceritinib Sales by Application (2027-2032) & (k pcs) Table 137. China Ceritinib Sales Price by Application (2021-2026) & (US$/pcs) Table 138. China Ceritinib Sales Price by Application (2027-2032) & (US$/pcs) Table 139. Asia Ceritinib Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia Ceritinib Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia Ceritinib Sales by Type (2021-2026) & (k pcs) Table 142. Asia Ceritinib Sales by Type (2027-2032) & (k pcs) Table 143. Asia Ceritinib Sales Price by Type (2021-2026) & (US$/pcs) Table 144. Asia Ceritinib Sales Price by Type (2027-2032) & (US$/pcs) Table 145. Asia Ceritinib Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia Ceritinib Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Ceritinib Sales by Application (2021-2026) & (k pcs) Table 148. Asia Ceritinib Sales by Application (2027-2032) & (k pcs) Table 149. Asia Ceritinib Sales Price by Application (2021-2026) & (US$/pcs) Table 150. Asia Ceritinib Sales Price by Application (2027-2032) & (US$/pcs) Table 151. Asia Ceritinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia Ceritinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Asia Ceritinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Asia Ceritinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 155. Asia Ceritinib Sales by Country (2021-2026) & (k pcs) Table 156. Asia Ceritinib Sales by Country (2027-2032) & (k pcs) Table 157. Asia Ceritinib Sales Price by Country (2021-2026) & (US$/pcs) Table 158. Asia Ceritinib Sales Price by Country (2027-2032) & (US$/pcs) Table 159. Japan Ceritinib Revenue (2021-2032) & (US$ Million) Table 160. South Korea Ceritinib Revenue (2021-2032) & (US$ Million) Table 161. India Ceritinib Revenue (2021-2032) & (US$ Million) Table 162. Australia Ceritinib Revenue (2021-2032) & (US$ Million) Table 163. Taiwan Ceritinib Revenue (2021-2032) & (US$ Million) Table 164. Southeast Asia Ceritinib Revenue (2021-2032) & (US$ Million) Table 165. SAMEA Ceritinib Revenue by Type (2021-2026) & (US$ Million) Table 166. SAMEA Ceritinib Revenue by Type (2027-2032) & (US$ Million) Table 167. SAMEA Ceritinib Sales by Type (2021-2026) & (k pcs) Table 168. SAMEA Ceritinib Sales by Type (2027-2032) & (k pcs) Table 169. SAMEA Ceritinib Sales Price by Type (2021-2026) & (US$/pcs) Table 170. SAMEA Ceritinib Sales Price by Type (2027-2032) & (US$/pcs) Table 171. SAMEA Ceritinib Revenue by Application (2021-2026) & (US$ Million) Table 172. SAMEA Ceritinib Revenue by Application (2027-2032) & (US$ Million) Table 173. SAMEA Ceritinib Sales by Application (2021-2026) & (k pcs) Table 174. SAMEA Ceritinib Sales by Application (2027-2032) & (k pcs) Table 175. SAMEA Ceritinib Sales Price by Application (2021-2026) & (US$/pcs) Table 176. SAMEA Ceritinib Sales Price by Application (2027-2032) & (US$/pcs) Table 177. SAMEA Ceritinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. SAMEA Ceritinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. SAMEA Ceritinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. SAMEA Ceritinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 181. SAMEA Ceritinib Sales by Country (2021-2026) & (k pcs) Table 182. SAMEA Ceritinib Sales by Country (2027-2032) & (k pcs) Table 183. SAMEA Ceritinib Sales Price by Country (2021-2026) & (US$/pcs) Table 184. SAMEA Ceritinib Sales Price by Country (2027-2032) & (US$/pcs) Table 185. Brazil Ceritinib Revenue (2021-2032) & (US$ Million) Table 186. Argentina Ceritinib Revenue (2021-2032) & (US$ Million) Table 187. Chile Ceritinib Revenue (2021-2032) & (US$ Million) Table 188. Colombia Ceritinib Revenue (2021-2032) & (US$ Million) Table 189. Peru Ceritinib Revenue (2021-2032) & (US$ Million) Table 190. Saudi Arabia Ceritinib Revenue (2021-2032) & (US$ Million) Table 191. Israel Ceritinib Revenue (2021-2032) & (US$ Million) Table 192. UAE Ceritinib Revenue (2021-2032) & (US$ Million) Table 193. Turkey Ceritinib Revenue (2021-2032) & (US$ Million) Table 194. Iran Ceritinib Revenue (2021-2032) & (US$ Million) Table 195. Egypt Ceritinib Revenue (2021-2032) & (US$ Million) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Ceritinib Distributors List Table 199. Ceritinib Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Ceritinib Image Figure 2. Global Ceritinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ceritinib Market Size Share 2021 VS 2025 VS 2032 Figure 4. 90 Capsules/Box Image Figure 5. 50 Capsules/Box Image Figure 6. 150 Capsules/Box Image Figure 7. Global Ceritinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Ceritinib Market Size Share 2021 VS 2025 VS 2032 Figure 9. Clinic Image Figure 10. Hospital Image Figure 11. Pharmacy Image Figure 12. Others Image Figure 13. Global Ceritinib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Ceritinib Revenue (2021-2032) & (US$ Million) Figure 15. Global Ceritinib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Ceritinib Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Ceritinib Revenue Market Share by Region (2021-2032) Figure 18. Global Ceritinib Sales (2021-2032) & (k pcs) Figure 19. Global Ceritinib Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 20. Global Ceritinib Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Ceritinib Sales YoY (2021-2032) & (k pcs) Figure 22. Europe Ceritinib Sales YoY (2021-2032) & (k pcs) Figure 23. China Ceritinib Sales YoY (2021-2032) & (k pcs) Figure 24. Asia (Excluding China) Ceritinib Sales YoY (2021-2032) & (k pcs) Figure 25. South America, Middle East and Africa Ceritinib Sales YoY (2021-2032) & (k pcs) Figure 26. Global Ceritinib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Ceritinib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Ceritinib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Ceritinib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Ceritinib Revenue Market Share by Type (2021-2032) Figure 32. Global Ceritinib Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 33. Global Ceritinib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Ceritinib Sales Market Share by Type (2021-2032) Figure 35. Global Ceritinib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Ceritinib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Ceritinib Revenue Market Share by Application (2021-2032) Figure 38. Global Ceritinib Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 39. Global Ceritinib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Ceritinib Sales Market Share by Application (2021-2032) Figure 41. North America Ceritinib Revenue Share by Type (2021-2032) Figure 42. North America Ceritinib Sales Share by Type (2021-2032) Figure 43. North America Ceritinib Revenue Share by Application (2021-2032) Figure 44. North America Ceritinib Sales Share by Application (2021-2032) Figure 45. North America Ceritinib Revenue Share by Country (2021-2032) Figure 46. North America Ceritinib Sales Share by Country (2021-2032) Figure 47. Europe Ceritinib Revenue Share by Type (2021-2032) Figure 48. Europe Ceritinib Sales Share by Type (2021-2032) Figure 49. Europe Ceritinib Revenue Share by Application (2021-2032) Figure 50. Europe Ceritinib Sales Share by Application (2021-2032) Figure 51. Europe Ceritinib Revenue Share by Country (2021-2032) Figure 52. Europe Ceritinib Sales Share by Country (2021-2032) Figure 53. China Ceritinib Revenue Share by Type (2021-2032) Figure 54. China Ceritinib Sales Share by Type (2021-2032) Figure 55. China Ceritinib Revenue Share by Application (2021-2032) Figure 56. China Ceritinib Sales Share by Application (2021-2032) Figure 57. Asia Ceritinib Revenue Share by Type (2021-2032) Figure 58. Asia Ceritinib Sales Share by Type (2021-2032) Figure 59. Asia Ceritinib Revenue Share by Application (2021-2032) Figure 60. Asia Ceritinib Sales Share by Application (2021-2032) Figure 61. Asia Ceritinib Revenue Share by Country (2021-2032) Figure 62. Asia Ceritinib Sales Share by Country (2021-2032) Figure 63. SAMEA Ceritinib Revenue Share by Type (2021-2032) Figure 64. SAMEA Ceritinib Sales Share by Type (2021-2032) Figure 65. SAMEA Ceritinib Revenue Share by Application (2021-2032) Figure 66. SAMEA Ceritinib Sales Share by Application (2021-2032) Figure 67. SAMEA Ceritinib Revenue Share by Country (2021-2032) Figure 68. SAMEA Ceritinib Sales Share by Country (2021-2032) Figure 69. Ceritinib Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Ceritinib Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 90 Capsules/Box
  • 50 Capsules/Box
  • 150 Capsules/Box
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Lucius Pharmaceuticals
  • Natco
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ceritinib Market by Type
  3. 1.2.1 Global Ceritinib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 90 Capsules/Box
  5. 1.2.3 50 Capsules/Box
  6. 1.2.4 150 Capsules/Box
  7. 1.3 Ceritinib Market by Application
  8. 1.3.1 Global Ceritinib Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Clinic
  10. 1.3.3 Hospital
  11. 1.3.4 Pharmacy
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Ceritinib Market Dynamics
  1. 2.1 Ceritinib Industry Trends
  2. 2.2 Ceritinib Industry Drivers
  3. 2.3 Ceritinib Industry Opportunities and Challenges
  4. 2.4 Ceritinib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ceritinib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ceritinib Revenue by Region
  3. 3.2.1 Global Ceritinib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ceritinib Revenue by Region (2021-2026)
  5. 3.2.3 Global Ceritinib Revenue by Region (2027-2032)
  6. 3.2.4 Global Ceritinib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ceritinib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ceritinib Sales by Region
  9. 3.4.1 Global Ceritinib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ceritinib Sales by Region (2021-2026)
  11. 3.4.3 Global Ceritinib Sales by Region (2027-2032)
  12. 3.4.4 Global Ceritinib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ceritinib Revenue by Manufacturers
  2. 4.1.1 Global Ceritinib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ceritinib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ceritinib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ceritinib Sales by Manufacturers
  6. 4.2.1 Global Ceritinib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ceritinib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ceritinib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ceritinib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ceritinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ceritinib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ceritinib Manufacturers, Product Type & Application
  13. 4.7 Global Ceritinib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ceritinib Market CR5 and HHI
  16. 4.8.2 2025 Ceritinib Tier 1, Tier 2, and Tier 3
5 Ceritinib Market by Type
  1. 5.1 Global Ceritinib Revenue by Type
  2. 5.1.1 Global Ceritinib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ceritinib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ceritinib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ceritinib Sales by Type
  6. 5.2.1 Global Ceritinib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ceritinib Sales by Type (2021-2032) & (k pcs)
  8. 5.2.3 Global Ceritinib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ceritinib Price by Type
6 Ceritinib Market by Application
  1. 6.1 Global Ceritinib Revenue by Application
  2. 6.1.1 Global Ceritinib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ceritinib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ceritinib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ceritinib Sales by Application
  6. 6.2.1 Global Ceritinib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ceritinib Sales by Application (2021-2032) & (k pcs)
  8. 6.2.3 Global Ceritinib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ceritinib Price by Application
7 Company Profiles
  1. 7.1 Lucius Pharmaceuticals
  2. 7.1.1 Lucius Pharmaceuticals Company Information
  3. 7.1.2 Lucius Pharmaceuticals Business Overview
  4. 7.1.3 Lucius Pharmaceuticals Ceritinib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Lucius Pharmaceuticals Ceritinib Product Portfolio
  6. 7.1.5 Lucius Pharmaceuticals Recent Developments
  7. 7.2 Natco
  8. 7.2.1 Natco Company Information
  9. 7.2.2 Natco Business Overview
  10. 7.2.3 Natco Ceritinib Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Natco Ceritinib Product Portfolio
  12. 7.2.5 Natco Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis Ceritinib Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis Ceritinib Product Portfolio
  18. 7.3.5 Novartis Recent Developments
8 North America
  1. 8.1 North America Ceritinib Market Size by Type
  2. 8.1.1 North America Ceritinib Revenue by Type (2021-2032)
  3. 8.1.2 North America Ceritinib Sales by Type (2021-2032)
  4. 8.1.3 North America Ceritinib Price by Type (2021-2032)
  5. 8.2 North America Ceritinib Market Size by Application
  6. 8.2.1 North America Ceritinib Revenue by Application (2021-2032)
  7. 8.2.2 North America Ceritinib Sales by Application (2021-2032)
  8. 8.2.3 North America Ceritinib Price by Application (2021-2032)
  9. 8.3 North America Ceritinib Market Size by Country
  10. 8.3.1 North America Ceritinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ceritinib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ceritinib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Ceritinib Market Size by Type
  2. 9.1.1 Europe Ceritinib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ceritinib Sales by Type (2021-2032)
  4. 9.1.3 Europe Ceritinib Price by Type (2021-2032)
  5. 9.2 Europe Ceritinib Market Size by Application
  6. 9.2.1 Europe Ceritinib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ceritinib Sales by Application (2021-2032)
  8. 9.2.3 Europe Ceritinib Price by Application (2021-2032)
  9. 9.3 Europe Ceritinib Market Size by Country
  10. 9.3.1 Europe Ceritinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ceritinib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ceritinib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Ceritinib Market Size by Type
  2. 10.1.1 China Ceritinib Revenue by Type (2021-2032)
  3. 10.1.2 China Ceritinib Sales by Type (2021-2032)
  4. 10.1.3 China Ceritinib Price by Type (2021-2032)
  5. 10.2 China Ceritinib Market Size by Application
  6. 10.2.1 China Ceritinib Revenue by Application (2021-2032)
  7. 10.2.2 China Ceritinib Sales by Application (2021-2032)
  8. 10.2.3 China Ceritinib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ceritinib Market Size by Type
  2. 11.1.1 Asia Ceritinib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ceritinib Sales by Type (2021-2032)
  4. 11.1.3 Asia Ceritinib Price by Type (2021-2032)
  5. 11.2 Asia Ceritinib Market Size by Application
  6. 11.2.1 Asia Ceritinib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ceritinib Sales by Application (2021-2032)
  8. 11.2.3 Asia Ceritinib Price by Application (2021-2032)
  9. 11.3 Asia Ceritinib Market Size by Country
  10. 11.3.1 Asia Ceritinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ceritinib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ceritinib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ceritinib Market Size by Type
  2. 12.1.1 SAMEA Ceritinib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ceritinib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ceritinib Price by Type (2021-2032)
  5. 12.2 SAMEA Ceritinib Market Size by Application
  6. 12.2.1 SAMEA Ceritinib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ceritinib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ceritinib Price by Application (2021-2032)
  9. 12.3 SAMEA Ceritinib Market Size by Country
  10. 12.3.1 SAMEA Ceritinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ceritinib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ceritinib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ceritinib Value Chain Analysis
  2. 13.1.1 Ceritinib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ceritinib Production Mode & Process
  6. 13.2 Ceritinib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ceritinib Distributors
  9. 13.2.3 Ceritinib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst